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ABSTRACT The 13 subunit of the cGMP phosphodi-
esterase (PDE) gene has been identified as the candidate gene
for retinal degeneration in the rd mouse. To study the molec-
ular mechanisms underlying degeneration and the potential for
gene repair, we have expressed a functional bovine cGMPPDE
(3 subunit in transgenic rd mice. One transgenic mouse line
showed complete photoreceptor rescue across the entire span of
the retina. A second independently derived line showed partial
rescue in which photoreceptors in the superior but not the
inferior hemisphere of the retina were rescued. In the latter
animals, intermediate stages of degeneration were observed in
the transition zone between rescued and diseased photorecep-
tors. Pathologic changes in the retina ranged from vesiculation
of the basalmost outer segment discs in otherwise structurally
intact rod cells to photoreceptors with highly disorganized
outer segments and intact inner segments. Totally or partially
rescued retinas showed a corresponding restoration of cGMP
PDE activity, whereas nonrescued retinas had minimal enzyme
activity, characteristic of the rd phenotype. These transgenic
animals provide models for studying the molecular basls of
retinal degenerative disease and conclusively demonstrate that
the phenotype of rd mice is produced by a defect in the (3
subunit of cGMP PDE.
The retinal degeneration phenotype of the rd mouse has
served as a model for the study ofhuman retinitis pigmentosa
for >30 years (1, 2). The degeneration is inherited in an
autosomal recessive fashion and is characterized by a rapid
initial loss of rod photoreceptor cells, first detectable by
electron microscopy at postnatal day 8, followed by loss of
cone photoreceptors (3, 4). By 30 days, a majority of pho-
toreceptor cells have degenerated, producing a severe thin-
ning of the entire retina, which results in apposition of the
retinal pigment epithelium with the remaining neurosensory
cells (5).
Biochemical studies comparing retinas from normal and rd
mice have shown elevated cGMP levels in rd photoreceptors
relative to wild type (6) with a concomitant reduction in
cGMP phosphodiesterase (PDE) activity prior to the appear-
ance of structural changes (7). These observations suggested
that the defect was in the tetrameric cGMP PDE enzyme,
which is composed of two large catalytic subunits, a and (,
and two small inhibitory y subunits (8, 9). Linkage mapping
has localized the cGMP PDE (3-subunit gene to the same
region on mouse chromosome 5 as the rd locus (10), whereas
the a and 'y subunits of cGMP PDE have been mapped to
other chromosomal locations (11, 12). These observations
correlate with the identification of the (3 subunit of cGMP
PDE as the defective candidate gene in rd mice (13, 14). In
addition, several mutations associated with the retinal de-
generation phenotype have been identified in the cGMP PDE
p-subunit gene (15, 16).
To examine the role of the cGMP PDE .3 subunit in
degeneration and gene repair, we have expressed the com-
plete cDNA of the gene in transgenic mice by using the 5'
flanking region of the mouse rod opsin gene to target it
specifically to photoreceptor cells. We describe here two
lines of transgenic mice that express the cGMP PDE (3-sub-
unit fusion gene. One line completely rescues the retinal
degeneration phenotype. A second line partially rescues the
defect. These results conclusively demonstrate that the
cGMP PDE 13 subunit is the site of the rd mutation.
MATERIALS AND METHODS
Transgene Construction. The transgene was made by liga-
tion of the 3.0-kilobase (kb) Kpn I/Xho I fragment encoding
the complete bovine cDNA of the cGMP PDE ,( subunit (17)
to the 4.4-kb Kpn I/Xho I mouse rod opsin 5' flanking region
(18). The 0.6-kb simian virus 40 polyadenylylation signal from
pGAL5 (18) was ligated to the 3' end of the PDE (3-subunit
cDNA, producing an 8-kb fusion gene construct (see Fig. 1).
All constructs were made in the pBluescript SK(-) vector
(Stratagene).
Transgenic Mouse Production and Analysis. Animal usage
was in accordance with institutional guidelines. The fusion
gene was introduced into fertile one-cell B6D2 F1 or FVB/n
mouse embryos (The Jackson Laboratory). B6D2 F1 mice
have the wild-type +/+ allele, while FVB/n mice are ho-
mozygous for the rd allele (19). Thus, founder animals
derived from B6D2 F1 mice were bred back into the
C57BL/6J rdle/rdle background before morphological anal-
ysis of retinas. The presence of the homozygous rd allele was
verified by PCR analysis across an rd-specific restriction
fragment length polymorphism containing an Msp I site.
Primers used were 5'-GACAGGCAAACTGAAGAGCT-3'
and 5'-GGCTG1TGATCCAAGACCCT-3'.
Southern blot analyses to identify founder animals and to
determine transgene copy number were run with 6 pug of
genomic mouse DNA prepared from tail samples (20). DNAs
were digested with HindIII or EcoPJ using conditions spec-
ified by the enzyme manufacturer (New England Biolabs).
Digested DNAs were run on a 0.5% agarose gel (SeaKemME
Agarose, FMC), transferred to nylon membrane (Zetabind,
Cuno), and baked dry. Blots were prehybridized in 50%o
formamide/0.5 M Na2HPO4/1 mM EDTA/1% bovine serum
albumin/5% SDS (21) and probed with either a rod opsin or
a PDE (3-subunit cDNA fragment radiolabeled by random
priming with [32P]dATP (22, 23). After overnight hybridiza-
Abbreviation: PDE, phosphodiesterase.
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FIG. 1. Fusion gene construct. The 4.4-kb murine rod opsin 5'
flanking region was ligated to the complete 3.0-kb bovine cGMP PDE
,-subunit cDNA to which the simian virus 40 (SV40) polyadenylyl-
ation signal was added. The 8.0-kb Kpn I/BamHI fragment was
microinjected into the male pronucleus of one-cell mouse embryos.
tion, blots were washed at high stringency with 2 x SSC (1x
SSC = 0.15 M NaCl/0.015 M sodium citrate)/0.1% SDS at
65°C and 0.1 x SSC/0.1% SDS at 65°C for 30 min under each
wash condition. Autoradiograms were developed after an
overnight exposure to Kodak XAR film. The three oligomers
used for PCR analysis for the presence of the transgene were
5'-GAATTCCCAAGAGGACTCTGGG-3', 5'-GACGTTG-
GAGAAGGGCACATAA-3', and 5'-CATGATCACAGC-
CACGACATC-3', amplifying a transgene fragment or an
endogenous rod opsin gene fragment as a control. All animals
analyzed were from the first, second, or third generation of
breeding from the founder mouse. Retinas from transgenic
mice were compared with nontransgenic age-matched sib-
lings ranging from postnatal day 10 to 3.5 months of age.
Tissue Processing of Mouse Eyes for Light and Electron
Microscopy. After sacrifice and before enucleation, the ori-
entation of mouse eyes was marked by passing an 8-0 nylon
suture through the superior pars plana. Eyes were then
opened through the inferior pars plana and fixed in 2%
paraformaldehyde/2% glutaraldehyde in 10 mM phosphate-
buffered saline (pH 7.2). Eyes were further postfixed in 4%
OS04, dehydrated in a graded ethanol series, and embedded
in Araldite 502 epoxy resin (CIBA Pharmaceutical).
cGMP PDE Assay. Eyes of transgenic and nontransgenic
siblings were marked for orientation and enucleated as de-
scribed above. Each eye was cut into superior and inferior
hemispheres. Retinal tissue from each hemisphere was ho-
mogenized in a buffer with 10 mM Tris'HCI, pH 7.5/1 mM
rd/rd (-)transgene
EDTA. cGMP PDE activity was assayed as described (6).
Briefly, the final reaction mixture contained 30 gg of retinal
extract, 0.4 mM [3H]cGMP (250,000 cpm), 5 mM MgCl2, and
40 mM Tris-HCl (pH 7.5) in a total vol of 100 p.l. Tubes were
incubated for 15 min at 370C, and the reaction was stopped by
boiling. After cooling, samples were incubated for 10 min at
370C with 0.3 unit of alkaline phosphatase. This second
reaction was stopped by addition of 1 ml ofAG1-X2 resin (50-
to 100-mesh; Cl- form, diluted 1:3, Bio-Rad). Tubes were left
standing for 30 min and then centrifuged at 3500 x g. Aliquots
of the supernatant were assayed. The percentage of retention
of guanosine by the resin was determined spectrophotomet-
rically, and the corresponding factor to correct for nucleoside
retention was introduced into the calculations for enzyme
activities.
RESULTS
The 8-kb mouse rod opsin/bovine cGMP PDE (3-subunit
cDNA fusion gene (Fig. 1) was expressed in pigmented
C57BL/6J rdle/rdle and albino FVB/n mice homozygous for
the rd allele. Founder transgenic animals were identified by
Southern blot and PCR analysis. Two lines of transgenic
animals, RP-33 in the FVB/n rd mouse line and RP4-28 in the
C57BL/6J rd/rd genetic background, expressed the trans-
gene. The RP33 transgenic line showed complete rescue of
photoreceptor cells (Fig. 2). RP4-28 mice exhibited partial
rescue of photoreceptor cells. Both transgenic mouse lines
had a single copy integration of the transgene as determined
by Southern blot hybridization.
Retinas from transgenic mouse line RP33 and nontrans-
genic age-matched control siblings were examined at post-
natal days 10, 15, 20, and 30 (Fig. 2). No obvious morpho-
logical difference between transgenic and nontransgenic ret-
inas was detectable at 10 days of age. However, at 15, 20, and
30 days of age, marked rescue of photoreceptor cells across
the entire span of the retina was discernable. Photoreceptor
cells from transgenic retinas were normal, whereas age-
matched control retinas showed severe loss of photoreceptor
inner and outer segments as well as a characteristic thinning
of the outer nuclear layer.
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FIG. 2. Light micrographs of retinas from RP33 siblings negative and positive for the PDE 8-subunit transgene at postnatal day 30. In the
retina negative for the transgene, photoreceptors have degenerated, such that the inner nuclear layer (inl) is directly apposed to the retinal
pigment epithelium (rpe). The transgenic retina appears normal, exhibiting complete outer plexiform (opl) and outer nuclear (onl) layers. A full
complement of rod and cone photoreceptors possessing full-length outer segments is present. ipl, Inner plexiform layer; gc, ganglion cells; ilm,
inner limiting membrane. (x225.)
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Retinas from transgenic mouse line RP4-28 and control
siblings were examined morphologically at postnatal days 10,
15, 30, and 60 and at 3.5 months of age. Like the RP33
transgenic line, no obvious morphological difference was
detectable at 10 days of age. However, at postnatal days 15,
30, and 60 and at 3.5 months, a superior temporal to inferior
nasal gradient of rescue was observed (Fig. 3a). Photorecep-
tors in the superior temporal region of the retina retained a
normal morphology, while photoreceptors in the inferior
nasal region had completely degenerated. In the central
retina, degeneration was intermediate in severity. This region
retained a full complement of photoreceptor nuclei and inner
segments, but most outer segments were highly disorganized
or absent. At the transition from superior to central retina,
rods were structurally intact, with the exception of abnormal
vesiculation of the basalmost disc membranes of the outer
segment (Fig. 4).
To correlate enzyme expression with photoreceptor res-
cue, levels of cGMP PDE activity were compared in RP4-28
and RP33 transgenic and nontransgenic age-matched sib-
lings. Retinas were bisected into superior and inferior hemi-
spheres and each hemisphere was assayed for cGMP PDE
activity (Fig. 5). Retinal samples from nontransgenic rd
siblings showed minimal or no activity. cGMP PDE activity
in the superior and inferior retinal hemispheres of one RP33
animal analyzed, approached that observed in wild-type +/+
animals. In two RP4-28 transgenic animals examined, the
level of enzyme activity in the superior hemispheres was
higher than in the inferior hemispheres. The lower cGMP
PDE activity of the inferior hemispheres correlates with
reduced numbers of rescued photoreceptors. These results
show that expression of the rod opsin/cGMP PDE 8-subunit
transgene is capable of restoring cGMP PDE activity.
DISCUSSION
We have expressed the normal bovine homologue of cGMP
PDE ,8 subunit, the candidate gene for mouse retinal degen-
eration, in transgenic mice homozygous for the endogenous
rd allele. The RP33 line of transgenic animals showed pho-
toreceptor rescue across the entire span of the retina (Fig. 2).
The RP4-28 line showed a superior to inferior gradient of
rescue (Fig. 3).
Both uniform and gradients of expression have been ob-
served in other transgenic mouse lines using the rod opsin
promoter (18, 24). The gradient of rescue in the RP4-28
transgenic mouse line (Fig. 3a) mirrors spatial expression
patterns previously reported in one transgenic mouse line
generated by using the mouse rod opsin promoter and the
Escherichia coli ,3-galactosidase reporter gene (18) (Fig. 3b).
Another transgenic line expressing the rod opsin/,B-
galactosidase transgene showed uniform 3-galactosidase ac-
tivity across the retina (18), similar to the complete rescue of
photoreceptor cells observed in the RP33 mouse line.
The spatial pattern of expression in the RP4-28 transgenic
mouse line appears to be dependent on upstream 5' flanking
sequences of the rod opsin gene. This pattern of expression
has been observed not only in constructs using ,B-galacto-
sidase (18) but also with rod and cone transducin structural
genes (J.L., M.I.S., C. Raport, and J. Hurley, unpublished
data). It is plausible that lower levels of expression lead to
intermediate levels of degeneration, including vesiculation
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FIG. 3. Light micrographs oftransgenic retinas. (a) Thirty-day-old RP4-28 transgenic mouse displays a gradient ofphotoreceptor rescue from
the superior (left) to the inferior (right) hemisphere. The superior retina has a normal complement of receptors with intact structure and
well-ordered outer segments. It is of normal thickness, with several rows of receptor nuclei comprising the outer nuclear layer (onl) (grid). The
rescue effect diminishes toward the inferior retina, resulting in a progressive loss of rods until a single row of cone nuclei remains (single boxes).
The central retina retains many receptors with intact inner segments but disorganized outer segments. (x 110.) (b) A superior to inferior gradient
of expression was also seen in an independently derived, nondegenerate line of transgenic animals expressing a rod opsin/f3-galactosidase fusion
gene (18). The onl is of uniform thickness from superior to inferior (grids). The 18-galactosidase reaction product (arrows) appears as two dark
bands sandwiching the onl caused by accumulation of reaction product in the inner segments and synaptic terminals of the rods. Staining is most
prominent in the superior aspect and diminishes in the inferior aspect of the retina. (x225.)
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FIG. 4. Electron micrograph of a rod from the central retina of a
30-day-old transgenic RP4-28 mouse. In this region of the retina, the
rods display vesiculated discs in the basal region of the outer
segment. Note the morphologically normal disc membranes above
this region synthesized just a few days earlier. (x37,800.)
observed at the base of otherwise structurally normal rod
outer segments. The presence of a large stack of intact disc
membranes in the outer segment above this vesiculation
suggests that the gradient of photoreceptor rescue may be the
result of a change in transgene expression. Abnormal disc
morphogenesis in the most recently synthesized discs sug-
gests that a decrease or shutdown of cGMP PDE subunit
may ultimately affect disc membrane formation. Alterna-
tively, an abnormal ratio of the transgene product relative to
other disc proteins may lead to vesiculation. Vesiculation
was not observed in retinas of RP33 transgenic animals nor
has it been reported in rd mice.
The asymmetry of rod opsin-driven transgene activity in
this animal model may extend its usefulness as a model of
retinitis pigmentosa in humans. Aberrant vesiculation has
previously been reported in a patient with retinitis pigmen-
tosa (25). In addition, recent reports of retinitis pigmentosa in
humans with the proline to histidine mutation in codon 23 of
the rhodopsin gene have described a "sectoral" distribution
of degeneration, in which the inferior hemisphere was the
most severely affected (26, 27).
FIG. 5. Histogram of cGMP PDE activities in 30-day-old trans-
genic vs. control rd/rd mice. cGMP PDE activity in the superior and
inferior retina hemispheres of completely rescued RP33 transgenic
mice approached levels observed in the C57BL/6J +/+ retinas. PDE
activity in retinas from two RP4-28 mice was examined. Lower levels
of activity in the inferior hemispheres correlated with fewer rescued
photoreceptors. Bars represent cGMP activities in individual retinal
samples obtained from the superior or inferior hemiretina based on
four determinations per sample. Error bars are 1 SD of the mean.
In summary, our results indicate that the expression of a
normal cGMP PDE p subunit is sufficient to restore cGMP
PDE activity and rescue photoreceptor cell degeneration in
both pigmented C57BL/6J and albino FVB/n rd mice. These
observations support the conclusion that the retinal degen-
eration phenotype arises from a defect in the cGMP PDE
p-subunit gene.
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